Osthole improves aspects of spatial performance in ovariectomized rats

Area of Science:

• Neuroscience
• Pharmacology
• Natural Products

Background:

• Cognitive deficits are a significant health concern, particularly in aging and post-menopausal populations.
• Scopolamine (SCOP) and ovariectomy (OVA) are established models for inducing spatial memory impairment in rodents.
• Cnidium monnieri (CM) is a traditional herb with potential cognitive-enhancing properties.

Purpose of the Study:

• To investigate the effects of CM and its active compound, osthole, on spatial memory deficits.
• To elucidate the potential mechanisms underlying osthole's effects, including estrogen-like activity and cholinergic system modulation.

Main Methods:

• Rats were treated with scopolamine (SCOP) or ovariectomized (OVA) to induce cognitive deficits.
• The effects of CM and varying doses of osthole (subcutaneous and intracerebroventricular) on spatial performance were assessed.
• Plasma estradiol levels and latency to reach a visible target were measured.

Main Results:

• CM administration improved spatial performance deficits in SCOP-treated rats and reversed decreased estradiol levels.
• Osthole administration (3 and 10 mg/kg, s.c.) ameliorated performance deficits in OVA rats.
• Osthole (10 and 30 µg/brain, icv) improved deficits in SCOP-treated and OVA rats, but did not affect visual target acquisition.

Conclusions:

• Osthole is an active constituent of CM with significant ameliorating effects on spatial memory deficits.
• Osthole's mechanism of action involves estrogen-like properties and activation of the central cholinergic system.
• These findings suggest potential therapeutic applications for osthole in managing cognitive impairments.